Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Simple monitoring tool could make labor safer and reduce C-Sections

NCT ID NCT07686419

Disease control Sponsor: Ain Shams University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 07, 2026 · Last updated Jul 08, 2026 · Updated 1 time

Summary

This trial tests a WHO-designed labor care guide—a simple monitoring tool—to see if it improves labor progress and increases the chance of a vaginal delivery. The study includes 350 full-term pregnant women planning a vaginal delivery at Ain Shams University Maternity Hospital. Researchers will measure healthcare provider satisfaction and compare delivery outcomes, labor duration, and maternal complications between those using the guide and those receiving standard care.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
labor care guide (a monitoring tool)
What this could lead to
If effective, this simple monitoring tool could help more women have safer, faster labors and avoid unnecessary C-sections.
What could go wrong
This is a single-hospital study, so results may not apply everywhere. The tool's success depends on how well healthcare providers use it.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

350 people

The number who actually took part.

Started

Apr 2025

Finished

Aug 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

15 to 45 months

Sex

Female participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Pregnant woman who will undergo vaginal delivery at Ain Shams University Maternity Hospital with gestational age above or equal 37 weeks 2. Vertex presentation . 3. Women with estimated fetal weight 2.5 till 4 kg Exclusion Criteria:: 1. Placenta previa 2. Placenta previa accreta 3. Macrosomic baby above 4 kg in diabetic women and above 4.5 kg in non diabetic women 4. Placenta abruption complicated by non reassuring CTG or life threatening bleeding 5. Cord prolapse 6. Vasa previa 7. Primary active genital herpes simplex 8. Patient with anemia which may lead to atonic uterus and prolonged labor. 9. Women with previously scarred uterus due to risk of ruptured uterus and postpartum hemorrhage

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Labor comfort are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Labor comfort

Contacts and locations

Locations

  • Ain Shams University Maternity Hospital

    Cairo, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.